Gene transfer into the CNS using recombinant adeno-associated virus: analysis of vector DNA forms resulting in sustained expression.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of drug targeting (Print)

• Publication date

  1999-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/10611869909085510PMID 10682906
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of Adeno-Associated Virus-Mediated Gene Transfer into the Rat Retina by Clinical Fluorescence Photography

  1999cited by this paper
• Highly Purified Recombinant Adeno-Associated Virus Vectors Are Biologically Active and Free of Detectable Helper and Wild-Type Viruses

  1999cited by this paper
• Generation of aberrant sprouting in the adult rat brain by GAP-43 somatic gene transfer.

  1999cited by this paper
• Gene therapy in the central nervous system: the use of recombinant retroviruses.

  1999cited by this paper
• Isolation of Recombinant Adeno-Associated Virus Vector-Cellular DNA Junctions from Mouse Liver

  1999cited by this paper
• Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of Expression

  1999cited by this paper
• The kinetics of rAAV integration in the liver

  1998cited by this paper
• Behavioral Recovery in 6-Hydroxydopamine-Lesioned Rats by Cotransduction of Striatum with Tyrosine Hydroxylase and Aromatic L-Amino Acid Decarboxylase Genes Using Two Separate Adeno-Associated Virus Vectors

  1998cited by this paper
• Adeno-Associated Virus Vector-Mediated Transgene Integration into Neurons and Other Nondividing Cell Targets

  1998cited by this paper
• Circular Intermediates of Recombinant Adeno-Associated Virus Have Defined Structural Characteristics Responsible for Long-Term Episomal Persistence in Muscle Tissue

  1998cited by this paper
• In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector

  1998cited by this paper
• Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats.

  1997cited by this paper
• Recombinant Adeno-Associated Viral Vectors Mediate Long-Term Transgene Expression in Muscle

  1997cited by this paper
• A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle

  1997cited by this paper
• Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters

  1997cited by this paper
• Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

  1997cited by this paper
• Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus.

  1997cited by this paper
• Recombinant adeno-associated virus for muscle directed gene therapy

  1997cited by this paper
• In vivo model of adeno-associated virus vector persistence and rescue

  1996cited by this paper
• Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors.

  1996cited by this paper
• A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors.

  1996cited by this paper
• Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

  1996cited by this paper
• Effects of Gamma Irradiation on the Transduction of Dividing and Nondividing Cells in Brain and Muscle of Rats by Adeno-Associated Virus Vectors

  1996cited by this paper
• Applications of gene therapy to the CNS.

  1996cited by this paper
• The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice

  1996cited by this paper
• Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein.

  1996cited by this paper
• The principles of gene therapy for the nervous system.

  1996cited by this paper
• Efficient transduction of human neurons with an adeno-associated virus vector.

  1996cited by this paper
• Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector.

  1996cited by this paper
• Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome

  1995cited by this paper
• Cell Lines for the Production of Recombinant Adeno-Associated Virus

  1995cited by this paper
• Development and application of herpes simplex virus vectors for human gene therapy.

  1995cited by this paper
• Adeno-associated virus vectors preferentially transduce cells in S phase.

  1994cited by this paper
• Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

  1994cited by this paper
• Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA.

  1994cited by this paper
• Targeted integration of adeno‐associated virus (AAV) into human chromosome 19.

  1991cited by this paper
• Site-specific integration by adeno-associated virus.

  1990cited by this paper
• Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression

  1989cited by this paper
• Adeno-associated virus general transduction vectors: analysis of proviral structures

  1988cited by this paper
• Oligonucleotide probes for the screening of recombinant DNA libraries.

  1987cited by this paper
• A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication

  1987cited by this paper
• Oligonucleotide probes for the screening of recombinant DNA libraries

  1987cited by this paper
• Evidence for a Single-Stranded Adenovirus-Associated Virus Genome: Isolation and Separation of Complementary Single Strands

  1970cited by this paper
• Selective extraction of polyoma DNA from infected mouse cell cultures.

  1967cited by this paper

• AAV-DJ is superior to AAV9 for targeting brain and spinal cord, and de-targeting liver across multiple delivery routes in mice

  2024cites this paper
• Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications

  2023cites this paper
• AAV-Mediated Gene Therapy for Research and Therapeutic Purposes

  2014cites this paper
• AAV-Mediated Gene Therapy for Research and Therapeutic Purposes.

  2014cites this paper
• Establishment of Recombinant Adeno-Associated Virus Vector Integration Frequency In Vitro and In Vivo

  2012cites this paper
• AAV-based approaches to model and treat spinal muscular atrophy

  2012cites this paper
• Evaluation of the fate of rAAV genomes following in vivo administration.

  2011cites this paper
• Adeno-Associated Virus Mediated Gene Therapy in Ischemic Stroke

  2010cites this paper
• Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN

  2010cites this paper
• Knockdown and overexpression of NR1 modulates NMDA receptor function.

  2009cites this paper
• Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-Arg.

  2006cites this paper
• Analgesic effects of AAV vector expressing GAD65 in the rat dorsal root ganglia on neuropathic pain

  2006cites this paper
• Recombinant adeno‐associated virus (rAAV) expressing TFPI‐2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line

  2005cites this paper
• Characterization of Adeno-Associated Virus Genomes Isolated from Human Tissues

  2005cites this paper
• Treatment with hydroxyurea and tyrphostin-1 significantly improves the transduction efficiency of recombinant adeno-associated viruses in human cancer cells.

  2005cites this paper
• Anticonvulsant and Antiepileptogenic Effects Mediated by Adeno-Associated Virus Vector Neuropeptide Y Expression in the Rat Hippocampus

  2004cites this paper
• Improving lipoplex-mediated gene transfer into C6 glioma cells and primary neurons.

  2004cites this paper
• Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain

  2003cites this paper
• HIV vaccine development: lessons from the past and promise for the future.

  2003cites this paper
• The promise of gene therapy in gastrointestinal and liver diseases

  2003cites this paper
• Genetic Fate of Recombinant Adeno-Associated Virus Vector Genomes in Muscle

  2003influential citation
• Recombinant adeno-associated virus vector design and gene expression in the mammalian brain.

  2002cites this paper
• Gene therapy: Recombinant adeno-associated virus vectors

  2001cites this paper
• Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.

  2000cites this paper
• Highly Purified Recombinant Adeno-Associated Virus Vectors Are Biologically Active and Free of Detectable Helper and Wild-Type Viruses

  1999cites this paper
• Evaluation of Adeno-Associated Virus-Mediated Gene Transfer into the Rat Retina by Clinical Fluorescence Photography

  1999cites this paper
• Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of Expression

  1999cites this paper